Loading…
Import this data to Google Sheets with:
=jivedata("AGNT","financials")Full statements spill as a table. For one cell: =jivedata("AGNT","Revenue") or =jivedata("AGNT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
AGNT • CIK 0001495932
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 |
|---|
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $126,864 | $113,607 | $124,245 | $111,162 |
| Restricted Cash, Current | $44,020 | $54,981 | $57,218 | $99,895 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $85,969 | $87,692 | $108,838 | $167,623 |
| Other Assets, Miscellaneous, Noncurrent | $7,400 | $11,679 | $23,495 | $23,155 |
| Prepaid Expense and Other Assets, Current | $9,622 | $11,692 | $14,567 | $12,715 |
| Intangible Assets, Net (Excluding Goodwill) | $10,481 | $6,456 | $4,421 | $4,924 |
| Stockholders' Equity Attributable to Parent | $242,839 | $204,869 | $242,779 | $280,852 |
| Assets, Current | $266,475 | $267,972 | $304,868 | $391,395 |
| Deferred Income Tax Assets, Net | $71,342 | $75,774 | $77,510 | $78,367 |
| Liabilities and Equity | $385,668 | $390,722 | $442,480 | $539,170 |
| Goodwill | $16,982 | $17,226 | $17,872 | $26,917 |
| Liabilities | $141,660 | $185,853 | $199,701 | $258,318 |
| Common Stock, Value, Issued | $2 | $2 | $2 | $2 |
| Additional Paid in Capital, Common Stock | $804,833 | $962,758 | $1,105,434 | $1,170,520 |
| Treasury Stock, Common, Value | $545,559 | $686,680 | $742,879 | $742,879 |
| Retained Earnings (Accumulated Deficit) | $-16,769 | $-68,135 | $-121,622 | $-145,550 |
| AOCI Including Portion Attributable to Noncontrolling Interest, before Tax | $332 | $-3,076 | $1,844 | $-1,241 |
| Accounts Payable, Current | $8,898 | $10,478 | $14,613 | $14,613 |
| Contract with Customer, Liability, Current | $44,550 | $55,660 | $57,204 | $91,293 |
| Accrued Liabilities, Current | $88,182 | $85,661 | $108,208 | $148,122 |
| Estimated Litigation Liability, Current | — | $34,000 | $17,000 | $3,335 |
| Other Liabilities, Current | — | — | $2,676 | $4,341 |
| Liabilities, Current | $141,640 | $185,853 | $199,701 | $258,318 |
| Accounts Receivable, Allowance for Credit Loss, Current | $2,303 | $1,589 | $2,690 | $2,687 |
| Common Stock, Shares Authorized | 900,000,000 | 900,000,000 | 900,000,000 | 900,000,000 |
| Common Stock, Shares, Issued | 183,606,708 | 195,028,207 | 207,785,762 | 213,853,720 |
| Common Stock, Shares, Outstanding | 154,669,037 | 154,133,385 | 161,049,979 | 167,117,937 |
| Treasury Stock, Common, Shares | 28,937,671 | 40,894,822 | 46,735,783 | 46,735,783 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-8,973 | $-21,267 | $-22,714 | $-17,190 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $-38 | $-2,972 | $4,274 | $-688 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $11,501 | $-1,305 | $12,875 | $26,123 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $170,884 | $168,588 | $181,463 | $189,598 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | — | $170,884 | $170,884 | $170,884 |
| Depreciation | $8,352 | $7,835 | $6,870 | $6,660 |
| Payments to Acquire Property, Plant, and Equipment | $5,363 | $6,483 | $9,569 | $9,139 |
| Amortization of Intangible Assets | $2,540 | $2,454 | $2,692 | $2,636 |
| Payments to Acquire Businesses, Gross | — | — | $6,150 | $6,150 |
| Proceeds from Sale of Equity Method Investments | $330 | $330 | $330 | $330 |
| Loss on Sale of Investments | $472 | $266 | $266 | $266 |
| Payments to Acquire Equity Method Investments | $5,876 | $5,447 | $13,246 | $1,589 |
| Provision for Other Credit Losses | $-1,711 | $-615 | $1,101 | $416 |
| Payments to Develop Software | $2,594 | $1,390 | $657 | $657 |
| Income (Loss) from Equity Method Investments | $-1,388 | $-1,168 | $-281 | $-276 |
| Net Cash Provided by (Used in) Investing Activities | $-13,503 | $-19,470 | $-23,472 | $-17,330 |
| Stock or Unit Option Plan Expense | $10,736 | $7,975 | $6,466 | $6,466 |
| Increase (Decrease) in Accounts Receivable | $-3,474 | $1,704 | $21,098 | $21,413 |
| Payments for Repurchase of Common Stock | $160,550 | $141,121 | $56,199 | $56,199 |
| Increase (Decrease) in Prepaid Expense | $1,263 | $-3,041 | $2,875 | $-2,669 |
| Proceeds from Stock Options Exercised | $4,980 | $2,012 | $434 | $84 |
| Increase (Decrease) in Deposits Outstanding | $-6,761 | $-11,110 | $-1,544 | $-1,289 |
| Payments to Noncontrolling Interests | — | $1,169 | $1,169 | $1,169 |
| Increase (Decrease) in Accounts Payable | $-1,491 | $1,690 | $4,135 | $-140 |
| Payments of Dividends | $28,519 | $30,099 | $30,773 | $31,637 |
| Increase (Decrease) in Accrued Liabilities | $8,424 | $-1,445 | $21,810 | $1,072 |
| Net Cash Provided by (Used in) Financing Activities | $-184,089 | $-170,377 | $-86,538 | $-57,883 |
| Increase (Decrease) in Other Operating Liabilities | $-4,677 | $-4,677 | $-4,677 | $-4,677 |
| Net Cash Provided by (Used in) Operating Activities | $209,131 | $191,514 | $118,611 | $102,024 |
| Income Taxes Paid, Net | $2,731 | $2,694 | $4,597 | $5,013 |